There are three medications available to treat chronic
Interferon (IFN): given to patients who have
an infection lasting greater than 6 months, with elevated liver enzymes, and
actively dividing virus in their blood. Approximately 40% of patients will respond to the therapy.
Lamivudine is taken by mouth once a month, and the
treatment lasts for one year. It is
sometimes given as a combination therapy with IFN. Approximately 40% of patients treated with Lamivudine will
respond to the therapy.
Hepsera® is an antiviral drug for the treatment of chronic hepatitis
B in adults with active viral replication and either evidence of persistent
elevations in serum aminotransferases (ALT or AST) or histologically active
disease. Hepsera works by blocking hepatitis B virus (HBV) DNA polymerase, an
enzyme crucial to the replication of the virus in the body. For more
information, click on:
This page was last modified on: 10/1/2012 09:07:26